Market Overview:
The global vitiligo therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of vitiligo, rising awareness about available treatment options, and growing demand for better-quality therapies. The global vitiligo therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into topical therapies, oral therapies, and others (including light therapy and surgical procedures). Topical therapies are further subsegmented into corticosteroids, calcineurin inhibitors (CNIs), psoralen plus ultraviolet A (PUVA) therapy,, narrowband ultraviolet B phototherapy (NB-UVB), broadband UVB phototherapy,, autologous melanocyte transplantation,, and other topical therapies. Oral therapies are further subsegmented into immunosuppressants,, antioxidants,, vitamin D analogs.,and others (including nutritional supplements). On the basis of application,. Hospital pharmacies accounted for the largest share of this market in 2017 owing to increased use of systemic treatments in hospitals. Retail pharmacies are expected to grow at a higher CAGR during the forecast period as they offer patients easy access to drugs.
Product Definition:
A vitiligo therapy is a treatment that is used to improve the appearance of skin affected by vitiligo. The purpose of vitiligo therapy is to stop or slow the progression of depigmentation, and to restore some degree of normal pigmentation. There are many different therapies available for vitiligo, including topical treatments, light therapy, and surgery.
Topical:
Topical drugs are used to treat the cause of the disease rather than the symptoms. They are used in cases where a patient has developed resistance to his/her own immune system and need external help. Topical drugs can be applied directly to the skin or can be taken by mouth. Some of them even remain active on the target for a longer period, helping in maintaining its function even when washed off.
Oral:
Oral is a drug delivery system that enables the delivery of therapeutic molecules to target tissues or organs in the body. It can be classified as an injectable, oral drug delivery device, and a self-administration kit. The most commonly used oral drugs are anti-inflammatory drugs such as topical corticosteroids and nonsteroidal anti-inflammatory drugs such as Aspirin (ASAP), Tylenol (TN), Paracetamol (Para).
Application Insights:
Based on application, the global vitiligo therapeutics market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy held the largest share of over 60.0% in 2017 owing to increasing prevalence of diseases such as diabetes and cancer which require regular medication. Moreover, hospitals offer better infrastructure facilities for storage and transportation which may increase demand for Vit-K2 supplements during treatment period.
The online pharmacy segment is expected to witness lucrative growth over the forecast period due to various benefits offered by internet including ease in access from any part of world with just a few clicks; tracking delivery status; insurance claims processing through eHealth systems etcetera (Growth Opportunities). However, there are certain disadvantages associated with internet based healthcare services such as security issues related to data entry point of view; privacy & confidentiality concerns among others (Threats To Growth). These threats can be minimized if proper safety measures are taken by operators while delivering goods through electronic medium i.
Regional Analysis:
North America dominated the global market in 2017. The presence of large patient populations and well-established healthcare facilities are some of the major factors contributing to its growth. Moreover, increasing awareness about vitiligo treatments is also expected to drive this region during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income, growing medical tourism, and an increase in demand for generic drugs due to lower price tags in countries like India & China as compared with developed nations like U.S., UK & Japan etc.
The Asia Pacific market was valued at USD X million in 2017 and is projected grow at a CAGR of XX% from 2018 till 2030 due to high unmet clinical needs coupled with rapidly improving healthcare infrastructure especially relatedto dermatology conditions such as vitiligo.
Growth Factors:
- Increasing prevalence of vitiligo
- Growing awareness about vitiligo and its treatment options
- Rising demand for novel and effective vitiligo therapies
- Technological advancements in vitiligo treatment therapies
- Growing number of clinical studies on new vitiligo treatments
Scope Of The Report
Report Attributes
Report Details
Report Title
Vitiligo Therapeutics Market Research Report
By Type
Topical, Oral, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Bausch Health, Baxter, Bristol-Myers Squibb, Celgene, Astellas Pharma, Aclaris Therapeutics, Puneet Laboratories, Clinuvel Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Vitiligo Therapeutics Market Report Segments:
The global Vitiligo Therapeutics market is segmented on the basis of:
Types
Topical, Oral, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Baxter
- Bristol-Myers Squibb
- Celgene
- Astellas Pharma
- Aclaris Therapeutics
- Puneet Laboratories
- Clinuvel Pharmaceuticals
Highlights of The Vitiligo Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical
- Oral
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vitiligo Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vitiligo Therapeutics is a biotechnology company that develops and commercializes treatments for vitiligo, a skin disorder caused by the loss of pigment in the skin. The company's products include topical creams and injections that restore lost pigment to affected areas of the skin. Vitiligo Therapeutics also offers clinical trials for new treatments for vitiligo.
Some of the key players operating in the vitiligo therapeutics market are Bausch Health, Baxter, Bristol-Myers Squibb, Celgene, Astellas Pharma, Aclaris Therapeutics, Puneet Laboratories, Clinuvel Pharmaceuticals.
The vitiligo therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vitiligo Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vitiligo Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vitiligo Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vitiligo Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vitiligo Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Vitiligo Therapeutics Market Size and Y-o-Y Growth
4.5.2 Vitiligo Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Vitiligo Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Vitiligo Therapeutics Market Size Forecast by Type
5.2.1 Topical
5.2.2 Oral
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Vitiligo Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Vitiligo Therapeutics Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vitiligo Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vitiligo Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Vitiligo Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Vitiligo Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Vitiligo Therapeutics Market Size Forecast by Type
9.6.1 Topical
9.6.2 Oral
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Vitiligo Therapeutics Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Vitiligo Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Vitiligo Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Vitiligo Therapeutics Market Size Forecast by Type
10.6.1 Topical
10.6.2 Oral
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Vitiligo Therapeutics Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Vitiligo Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Vitiligo Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Vitiligo Therapeutics Market Size Forecast by Type
11.6.1 Topical
11.6.2 Oral
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Vitiligo Therapeutics Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Vitiligo Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Vitiligo Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Vitiligo Therapeutics Market Size Forecast by Type
12.6.1 Topical
12.6.2 Oral
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Vitiligo Therapeutics Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Vitiligo Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Vitiligo Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Vitiligo Therapeutics Market Size Forecast by Type
13.6.1 Topical
13.6.2 Oral
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Vitiligo Therapeutics Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vitiligo Therapeutics Market: Competitive Dashboard
14.2 Global Vitiligo Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Baxter
14.3.3 Bristol-Myers Squibb
14.3.4 Celgene
14.3.5 Astellas Pharma
14.3.6 Aclaris Therapeutics
14.3.7 Puneet Laboratories
14.3.8 Clinuvel Pharmaceuticals
